• Cefuroxime for Injection with GMP 0.75g/1.5g
  • Cefuroxime for Injection with GMP 0.75g/1.5g
  • Cefuroxime for Injection with GMP 0.75g/1.5g
  • Cefuroxime for Injection with GMP 0.75g/1.5g

Cefuroxime for Injection with GMP 0.75g/1.5g

Application: Internal Medicine
Usage Mode: For external use
Suitable for: Elderly, Children, Adult
State: Solid
Shape: Oral Liquid
Type: Organic Chemicals
Samples:
US$ 0.001/Piece 1 Piece(Min.Order)
| Request Sample
Customization:
Diamond Member Since 2019

Suppliers with verified business licenses

Manufacturer/Factory & Trading Company

Basic Info.

Model NO.
0.75g/1.5g
Pharmaceutical Technology
Chemical Synthesis
Drug Reg./Approval No.
H20013187
Indate
3years
Sterile
Sterile
Color
White
Standard
Bp/Cp
Transport Package
50vials/Tray/Box, 20boxes/Carton
Specification
0.75g/1.5g
Trademark
Reyoung
Origin
China
HS Code
3003101900
Production Capacity
20000000vials/Year

Product Description

Product name Cefuroxime for injection
Specificaton 0.75g/1.5g
Certification GMP ISO9001 ISO14001
Standard BP/CP
fuction Cefuroxime sodium for injection is suitable for unspecified bacterial infections or infections caused by sensitive bacteria.
In addition, the product can also be used to prevent a variety of postoperative infections.
It is usually effective on its own, but may be used in combination with aminoglycoside antibiotics or metronidazole (oral, suppositories, and injections) if appropriate, especially in colon surgery to prevent infection.
taboo This product is contraindicated for those allergic to cephalosporin or cephalosporin.
Announcements 1. There is cross-allergic reaction between this product and penicillin.
This product should be used with caution if allergic to penicillin drugs.
Penicillin anaphylactic shock, should not be used again this product.
2. When using this product, attention should be paid to monitoring renal function, especially for severe patients receiving high dose.
3, renal insufficiency should reduce the daily dose.
Patients treated with a combination of powerful diuretics or aminoglycoside antibiotics should be given special attention because renal function damage has been reported in combination therapy.
For these patients, renal function monitoring is preferred.
4, this product can cause false membranous enteritis, with a history of gastrointestinal disease, especially colitis ulcerative colitis, limited or antibiotics associated colitis patients, should be vigilant.
After the diagnosis of pseudomembranous enteritis is established, appropriate treatment should be given.
For mild cases, drug withdrawal is enough; for moderate and severe cases, liquid, electrolyte and protein supplementation should be provided, and antibiotics effective for clostridium difficile should be selected for treatment.
5. It has been reported that a small number of children have mild and moderate hearing impairment when using this product.
6. Compatibility and Stability:
Intramuscular injection: when prepared with sterilized water for injection, the suspension of this product can be kept active at room temperature for 24 hours and stored at 5ºC in refrigerator for 48 hours.
After this period, any unused solution should be discarded.
Intravenous injection: When prepared with sterilized water for injection, the solution prepared with 750mg and 1.5g can remain active at room temperature for 24 hours and stored at 5ºC in refrigerator for 48 hours.
The product is compatible with heparin (10-50u/ mL), potassium chloride (10-40meq/L), 0.9% sodium chloride at room temperature for 24 hours.
This product is 750mg and 1.5g, diluted with 50ml or 100mL 5% glucose injection, 0.9% sodium chloride injection and 0.45% sodium chloride injection. It can be stored at room temperature for 24 hours and stored in refrigerator for 7 days.
7. Interference to diagnosis: This product can interfere with the direct Coombs test results, resulting in a positive reaction, which will interfere with the cross coordination of blood;
False positives can occur when a Benedicte or Feline test or Clintest Tabets test examines urine sugar, but not when the enzyme approach is used.
False negative results can be obtained if ferricyanic acid method is used in blood glucose examination, and cefuroxime sodium will not interfere with the determination of urine and serum inosine values by alkaline picric acid method.



Cefuroxime for Injection with GMP 0.75g/1.5g
Cefuroxime for Injection with GMP 0.75g/1.5g
Cefuroxime for Injection with GMP 0.75g/1.5g
Cefuroxime for Injection with GMP 0.75g/1.5g
Cefuroxime for Injection with GMP 0.75g/1.5g
Cefuroxime for Injection with GMP 0.75g/1.5g
Cefuroxime for Injection with GMP 0.75g/1.5g
Cefuroxime for Injection with GMP 0.75g/1.5g




















 

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now

You Might Also Like

Diamond Member Since 2019

Suppliers with verified business licenses

Manufacturer/Factory & Trading Company
Number of Employees
4950
Management System Certification
ISO9001:2015, ISO14001:2015, OHSAS18001:2007, GMP, GMP, GMP, GMP, GMP, GMP